ArticleBMC cancer2009

APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling.

Russell D Petty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.